A multistakeholder approach to innovations in NAFLD care

Jörn M Schattenberg; Alina M Allen; Helen Jarvis; Shira Zelber-Sagi; Ken Cusi; John F Dillon; Cyrielle Caussy; Sven M Francque; Zobair Younossi; Naim Alkhouri; Jeffrey V Lazarus

doi:10.1038/s43856-022-00228-y

A multistakeholder approach to innovations in NAFLD care

Commun Med (Lond). 2023 Jan 3;3(1):1. doi: 10.1038/s43856-022-00228-y.

Authors

Jörn M Schattenberg¹, Alina M Allen², Helen Jarvis³, Shira Zelber-Sagi^{4

5}, Ken Cusi⁶, John F Dillon⁷, Cyrielle Caussy^{8

9}, Sven M Francque^{10

11}, Zobair Younossi¹², Naim Alkhouri¹³, Jeffrey V Lazarus^{14

15

16}

Affiliations

¹ Metabolic Liver Research Program, I. Department of Medicine, University Medical Center, Mainz, Germany.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
³ Department of Primary Care, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
⁴ School of Public Health, University of Haifa, Haifa, Israel.
⁵ Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
⁶ Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
⁷ Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, United Kingdom.
⁸ Univ Lyon, CarMen Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon, Pierre-Bénite, France.
⁹ Hospices Civils de Lyon, Département Endocrinologie, Diabète et Nutrition, Hôpital Lyon Sud, Pierre-Bénite, France.
¹⁰ Department of Gastroenterology Hepatology, Antwerp University Hospital, Edegem, Belgium.
¹¹ InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
¹² Center for Liver Disease, Inova Medicine, Falls Church, VA, USA.
¹³ Fatty Liver Program, Arizona Liver Health, Phoenix, AZ, USA.
¹⁴ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. [email protected].
¹⁵ CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. [email protected].
¹⁶ Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. [email protected].

Abstract

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent globally and requires multidisciplinary care. Here, we report key findings of a NAFLD care workshop, address knowledge gaps and highlight a path to optimise healthcare resource use, to improve outcomes in patients with steatotic liver disease.